Category: Consultation Responses

Epilepsy in Australia

Epilepsy is one of the most common chronic brain conditions, affecting how people think, work, learn and live. Without reform, the projected cost over the next decade is stark: 15,227 deaths and nearly A$19.9 billion in healthcare costs by 2033. Australia has a strong national record in epilepsy research. In…

Review of Human Tissue Laws

Every major advance in modern medicine rests on acts of public trust, which in many cases, is the decision to donate human tissue for research. From cancer immunotherapies to regenerative medicine, Australia’s health and medical research system depends on ethical, well-governed frameworks that honour that trust and keep pace with…

AAHMS submission on the draft National Health and Research Strategy

The Australian Academy of Health and Medical Sciences (AAHMS) has made a submission to the Commonwealth Department of Health, Disability and Ageing’s consultation on the draft National Health and Medical Research Strategy 2026–2036. The Academy welcomes the release of Australia’s first overarching national strategy for health and medical research,…

AAHMS Response – Strategic Examination of Research and Development

The Australian Academy of Health and Medical Sciences submitted a response to the Australian Government’s Strategic Examination of Research and Development (SERD) in April 2025. Our submission highlighted the need for: The Academy’s full submission can be read below. 

Submission on ARC’s National Competitive Grants Program

The Australian Academy of Health and Medical Sciences (AAHMS) submitted a response to the Australian Research Council’s (ARC) Policy Review of the National Competitive Grants Program (NCGP) in April 2025. Our submission emphasised the need for: Academy CEO Ms Catherine Luckin said that the Academy’s submission to…

AAHMS calls for a national biomonitoring program to track the health impacts of forever chemicals

The Academy of Health and Medical Sciences has made four recommendations to the Senate Select Committee on PFAS, on how Australian policy and decision makers could respond to the challenge of monitoring and mitigating for these ‘forever chemicals’ and their potential health impacts. Per- and polyfluoroalkyl substances (PFAS)…

Submission: NHMRC Good Institutional Practice Guide

The Academy of Health and Medical Sciences is pleased to provide feedback on the National Health and Medical Research Council’s consultation draft of the Good Institutional Practice Guide.  The NHMRS Good Institutional Practice Guide provides a solid foundation for fostering a positive research culture and maintaining high standards in research…

2024-25 Pre-Budget submission

In January 2024, the Academy responded to the Federal Government’s call for Pre-Budget submissions. AAHMS’ submission encouraged the Government to maximise the value of health and medical research investments, drawing on recommendations from the Academy’s 2022 report,  Research and innovation as core functions in transforming the health…

Submission: COVID-19 Response Inquiry

In December 2023, the Academy provided a submission to the Australian Government’s COVID-19 Response Inquiry. This submission responds to the Inquiry terms of reference 2, 3 and 8 as they relate to the health and medical research landscape and the translation of research into evidence-based policy and…